Sun Genomics

company

About

Sun Genomics provides personalized probiotic solutions based on AI and whole-genome sequencing of the microbiome.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$9.25M
Industries
Biotechnology,Health Care,Medical,Nutrition,Personal Health
Founded date
Jan 1, 2016
Number Of Employee
11 - 50
Operating Status
Active

Sun Genomics is a microbiome health company focused on curing dysbiosis through personalized probiotics. its flagship product Floré, a microbiome test and gut probiotics solution that utilizes whole-genome sequencing to evaluate different digestive system data points and ensure that customers receive a completely personalized product that is based on their unique gut profiles. The company also offers Floré Tots, which is available for kids up to age 12 and comes in an easy digestive powder to mix with their favorite drink.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$9.25M
Sun Genomics has raised a total of $9.25M in funding over 2 rounds. Their latest funding was raised on Jun 29, 2020 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 29, 2020 Series A $9.25M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Sun Genomics is funded by 1 investors. Nascita Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Nascita Ventures Series A